Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis
- PMID: 12562873
- DOI: 10.1194/jlr.M200342-JLR200
Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis
Abstract
Familial hypobetalipoproteinemia (FHBL) subjects may develop fatty liver. Liver fat was assessed in 21 FHBL with six different apolipoprotein B (apoB) truncations (apoB-4 to apoB-89) and 14 controls by magnetic resonance spectroscopy (MRS). Liver fat percentages were 16.7 +/- 11.5 and 3.3 +/- 2.9 (mean +/- SD) (P = 0.001). Liver fat percentage was positively correlated with body mass index, waist circumference, and areas under the insulin curves of 2 h glucose tolerance tests, suggesting that obesity may affect the severity of liver fat accumulation in both groups. Despite 5-fold differences in liver fat percentage, mean values for obesity and insulin indexes were similar. Thus, for similar degrees of obesity, FHBL subjects have more hepatic fat. VLDL-triglyceride (TG)-fatty acids arise from plasma and nonplasma sources (liver and splanchnic tissues). To assess the relative contributions of each, [2H2]palmitate was infused over 12 h in 13 FHBL subjects and 11 controls. Isotopic enrichment of plasma free palmitate and VLDL-TG-palmitate was determined by mass spectrometry. Non-plasma sources contributed 51 +/- 15% in FHBL and 37 +/- 13% in controls (P = 0.02). Correlations of liver fat percentage and percent VLDL-TG-palmitate from liver were r = 0.89 (P = 0.0001) for FHBL subjects and r = 0.69 (P = 0.01) for controls. Thus, apoB truncation-producing mutations result in fatty liver and in altered assembly of VLDL-TG.
Similar articles
-
Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.J Lipid Res. 2004 May;45(5):941-7. doi: 10.1194/jlr.M300508-JLR200. Epub 2004 Feb 16. J Lipid Res. 2004. PMID: 14967820
-
Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2714-21. doi: 10.1161/01.atv.19.11.2714. Arterioscler Thromb Vasc Biol. 1999. PMID: 10559016 Clinical Trial.
-
Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.Metabolism. 2005 May;54(5):682-8. doi: 10.1016/j.metabol.2004.12.013. Metabolism. 2005. PMID: 15877300
-
Familial hypobetalipoproteinemia: genetics and metabolism.Cell Mol Life Sci. 2005 Jun;62(12):1372-8. doi: 10.1007/s00018-005-4473-0. Cell Mol Life Sci. 2005. PMID: 15818469 Free PMC article. Review.
-
Familial hypobetalipoproteinemia: a review.J Lipid Res. 2003 May;44(5):878-83. doi: 10.1194/jlr.R300002-JLR200. Epub 2003 Mar 16. J Lipid Res. 2003. PMID: 12639976 Review.
Cited by
-
Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia.Curr Atheroscler Rep. 2010 Jan;12(1):58-65. doi: 10.1007/s11883-009-0078-7. Curr Atheroscler Rep. 2010. PMID: 20425272 Review.
-
Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014.Eur J Hum Genet. 2015 Jun;23(6):890-. doi: 10.1038/ejhg.2014.225. Epub 2014 Oct 22. Eur J Hum Genet. 2015. PMID: 25335495 Free PMC article. No abstract available.
-
The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.Hepatology. 2017 Oct;66(4):1111-1124. doi: 10.1002/hep.29273. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28520213 Free PMC article.
-
Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes.J Lipid Res. 2020 Jul;61(7):1065-1074. doi: 10.1194/jlr.RA120000669. Epub 2020 May 11. J Lipid Res. 2020. PMID: 32393551 Free PMC article. Clinical Trial.
-
Hypobetalipoproteinemia and abetalipoproteinemia.Curr Opin Lipidol. 2014 Jun;25(3):161-8. doi: 10.1097/MOL.0000000000000072. Curr Opin Lipidol. 2014. PMID: 24751931 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous